A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin-Vinorelbine-Cetuximab in Patients With Stage III Non-Small-Cell Lung Cancer

Anne-Marie C. Dingemans*, Gerben Bootsma, Angela van Baardwijk, Bart Reymen, Rinus Wanders, Boudewijn Brans, Marco Das, Monique Hochstenbag, Arne van Belle, Ruud Houben, Philippe Lambin, Dirk de Ruysscher

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin-Vinorelbine-Cetuximab in Patients With Stage III Non-Small-Cell Lung Cancer'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science